Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

NCT06355258 is registered in ClinicalTrials.gov with Westlake University as lead sponsor.

NCT NCT06355258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
Lead sponsor
Westlake University
Phase
Phase 1
Overall status
Recruiting
Start date
December 15, 2023
Completion date
March 31, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19 associated coagulopathy